Table 3.

Aspirin plus ticlopidine versus aspirin plus oral anticoagulants after stenting

			Primary end point (%)
	Number of	Number of
Study	patients studied	patients treated	ASA ticlopidine	ASA coumadin	ASA alone	P value
ISAR [84]	517	626	1.6	6.2	-	0.01
FANTASTIC [85]	473	485	5.7	8.6	-	0.37
STARS [86]	1653	1965	0.5	2.7	3.6	0.001
MATTIS [87]	350	350	5.6	11.0	-	0.07
Hall et al [88]	226	358	0.8	-	3.9	0.1

In the ISAR, STARS, MATTIS and Hall et al studies, the primary end point comprised cardiac death, acute myocardial infarction or repeat target vessel revascularization at 30 days. In the FANTASTIC study, the composite of death, acute myocardial infarction or stent occlusion at 6 weeks was the secondary end point and did not include repeat target revascularization.